Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00263055 |
Safety & tolerability of FOLFOX4 regimen in the adjuvant treatment of colon cancer in Asian patients
Condition | Intervention | Phase |
---|---|---|
Colonic Neoplasms |
Drug: oxaliplatin |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety Study |
Official Title: | Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV |
Study Start Date: | August 2004 |
Primary Completion Date: | June 2005 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion criteria
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
China | |
Sanofi-Aventis | |
Beijing, China | |
Hong Kong | |
Sanofi-Aventis | |
Hong Kong, Hong Kong | |
Korea, Republic of | |
Sanofi-aventis | |
Seoul, Korea, Republic of | |
Taiwan | |
Sanofi-Aventis | |
Taipei, Taiwan | |
Thailand | |
Sanofi-Aventis | |
Bangkok, Thailand |
Study Director: | Claude Valterio, MD | Sanofi-Aventis |
Responsible Party: | sanofi-aventis ( Medical Affairs Study Director ) |
Study ID Numbers: | R_9262 |
Study First Received: | December 6, 2005 |
Last Updated: | July 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00263055 |
Health Authority: | China: Ministry of Health |
Oxaliplatin Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Fluorouracil Colonic Diseases |
Gastrointestinal Neoplasms Intestinal Diseases Colonic Neoplasms Intestinal Neoplasms Colorectal Neoplasms |
Neoplasms Neoplasms by Site Antineoplastic Agents Therapeutic Uses Pharmacologic Actions |